Home > Income Statement > CONCORD BIOTECH

CONCORD BIOTECH
Consolidated Net Profit

    Back to Income Statement
CONCORD BIOTECH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
AD     Remove this Ad

CONCORD BIOTECH Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹308 Cr₹240 Cr₹17 Cr₹235 Cr₹1,690 Cr

What is the latest Consolidated Net Profit of CONCORD BIOTECH ?

The latest Consolidated Net Profit ratio of CONCORD BIOTECH is ₹308 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹308 Cr
Mar2024₹240 Cr
Mar2023₹17 Cr
Mar2022₹235 Cr
Mar2021₹1,690 Cr

How is Consolidated Net Profit of CONCORD BIOTECH Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹308 Cr
28.33
Mar2024 ₹240 Cr
1,272.47
Mar2023 ₹17 Cr
-92.55
Mar2022 ₹235 Cr
-86.10
Mar2021 ₹1,690 Cr -

Compare Consolidated Net Profit of peers of CONCORD BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD BIOTECH ₹12,286.8 Cr -5.8% -12.7% -43.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹382,694.0 Cr -2.3% -7.3% -12.8% Stock Analytics
DIVIS LABORATORIES ₹160,721.0 Cr 0.8% -5.8% 4.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹134,016.0 Cr 0.8% 3.7% 20.8% Stock Analytics
CIPLA ₹106,946.0 Cr 0.7% -11.2% -6.5% Stock Analytics
DR REDDYS LABORATORIES ₹101,691.0 Cr -1.4% -3.8% -1.3% Stock Analytics


CONCORD BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD BIOTECH

-5.8%

-12.7%

-43.2%

SENSEX

-0.1%

-2.9%

7.5%


You may also like the below Video Courses